author-photo

Ludivine Kouton

11

Papers

52

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.

2021 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (7)
Neurographie par résonance magnétique quantitative chez des patients atteints d’une neuropathie de Charcot–Marie–Tooth avec mutation dans le gène MPZ

2021 Revue Neurologique
Show All
- Source
- Cite
- Save
Citations (0)
Pattern de l’atteinte musculaire et suivi longitudinal en IRM musculaire quantitative de patients atteints de dystrophie musculaire facio-scapulo-humerale de type 1 (FSHD1)

2021 Revue Neurologique
Show All
- Source
- Cite
- Save
Citations (0)
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype: Neurology - Neuroimmunology Neuroinflammation

2020 Neuroimmunology and Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (0)
Motor unit number index as an individual biomarker: reference limits of intra-individual variability over time in healthy subjects

2020 Clinical Neurophysiology
Show All
- Source
- Cite
- Save
Citations (3)
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting Neurofascin 155 or Contactin1 glycoproteins

2020 Clinical Neurophysiology
Show All
- Source
- Cite
- Save
Citations (17)
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.

2020 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (25)
Étude prospective multicentrique d'une cohorte de patients atteints de polyradiculonévrite chronique associée à des anticorps dirigés contre le nœud de Ranvier : caractéristiques cliniques, biologiques et électrophysiologiques

2018
- Ludivine Kouton
Show All
- Source
- Cite
- Save
Citations (0)